Galderma announced the availability of a new nozzle for Clobex (clobetasol propionate) Spray, a topical steroid indicated for the treatment of moderate to severe plaque psoriasis in adults ≥18 years ...

Nov. 10, 2005 -- The U.S. Food and Drug Administration (FDA) has approved clobetasol propionate 0.05% spray for the treatment of moderate to severe plaque psoriasis affecting up to 20% of body surface ...

Shares of Glenmark Pharma rose 1 percent intraday Tuesday as it has received ANDA approval for Clobetasol Propionate Spray. Glenmark Pharmaceuticals Inc. USA has been granted final approval by the ...

Glenmark Pharmaceuticals Inc, USA has received final approval by the United States Food & Drug Administration (USFDA) for Clobetasol Propionate spray 0.05 per cent, the company said. New Delhi: ...

Drug firm Zydus Cadila has received approval from the US health regulator to market fluconazole tablets used for the treatment of fungal infections. Advisory Alert: It has come to our attention that ...

Perrigo Received FDA Approval for Generic Prandin Perrigo announced the launch of Clobetasol Propionate Spray 0.05% , the generic version of Galderma's Clobex Spray. Perrigo announced the launch of ...

Alembic Pharmaceuticals on Friday said its joint venture (JV) firm Aleor Dermaceuticals has received approval from the US health regulator for Clobetasol Propionate spray, used to treat plaque ...

NEW YORK, Sept. 05, 2024 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (NASDAQ: EYEN), a commercial-stage ophthalmic company with two FDA-approved products and a late-stage asset in development for the treatment ...

Product-candidate would incorporate new steroid with the Optejet® for the millions of dry eye patients who experience periodic flare-ups NEW YORK, Aug. 07, 2024 (GLOBE NEWSWIRE) -- Eyenovia, Inc.

Laser therapy plus topical effective for generalized plaque psoriasis Combination treatment avoids side effects often seen with systemic therapy. Ethan C. Levin, MD, Psoriasis and Skin Treatment ...

Glenmark Pharmaceuticals has received final nod from the US health regulator for its Clobetasol Propionate spray used for the treatment of moderate to severe plaque psoriasis in adults. Glenmark ...

NEW YORK, Aug. 07, 2024 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (NASDAQ: EYEN), a commercial-stage ophthalmic company with two FDA-approved products and a late-stage asset in pediatric progressive myopia, ...